The Treatment Path in Hepatocellular Carcinoma

Supplement 9 Abstract: The treatment approach for hepatocellular carcinoma (HCC) depends on the stage and extent of disease, the severity of the underlying liver disease, and the […]

The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma

H&O Do biomarkers currently have a role in hepatocellular carcinoma? PJ The role of biomarkers in hepatocellular carcinoma (HCC) is controversial. For example, the best-known […]

The Role of Regorafenib in Hepatocellular Carcinoma

H&O What is the mechanism of action of regorafenib? CF The mechanism of action of regorafenib (Stivarga, Bayer) is very similar to that of sorafenib […]

Liver Transplant and Hepatocellular Carcinoma

Clinical Advances in Hematology & Oncology December 2016, Volume 14, Issue 12 Robert Wong, MD, MS Assistant Clinical Professor of Medicine Director of Research and Education […]

Novel Second-Line Treatments for Hepatocellular Carcinoma

Moderator Richard S. Finn, MD Discussants Catherine T. Frenette, MD, FAST, and Riccardo Lencioni, MD Abstract: There are 3 management approaches for patients with newly diagnosed hepatocellular carcinoma […]

The Role of Liver Biopsy in Hepatocellular Carcinoma

Clinical Advances in Hematology & Oncology October 2016, Volume 14, Issue 10 Richard S. Finn, MD Associate Professor of Medicine Department of Medicine Division of Hematology/Oncology […]